[Angiokeratoma regression in a Fabry disease after treatment with agalsidase-beta: clinical effectiveness marker?]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine.
Gene-disease associations manually curated.
DisGeNET evidence - CURATED